Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
Clinical trial NCT02279732 · COMPLETED
Trial details
- NCT number
- NCT02279732
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2018-05-03
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.